Medical Tourism Market (By Treatment Type: Dental Treatment, Cardiovascular Treatment, Cancer Treatment, Cosmetic Treatment, Orthopedic Treatment, Fertility Treatment, Neurological Treatment, and Other Treatment) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 - 2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Tourism Market 

5.1. COVID-19 Landscape: Medical Tourism Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Tourism Market, By Treatment Type

8.1. Medical Tourism Market, by Treatment Type, 2023-2032

8.1.1. Dental Treatment

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Cardiovascular Treatment

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Cancer Treatment

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Cosmetic Treatment

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Orthopedic Treatment

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Fertility Treatment

8.1.6.1. Market Revenue and Forecast (2020-2032)

8.1.7. Neurological Treatment

8.1.7.1. Market Revenue and Forecast (2020-2032)

8.1.8. Other

8.1.8.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Medical Tourism Market, By Service Providers

9.1. Medical Tourism Market, by Service Providers, 2023-2032

9.1.1. Public

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Private

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Medical Tourism Market, By Type 

10.1. Medical Tourism Market, by Type, 2023-2032

10.1.1. Domestic

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. International

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Medical Tourism Market, By Healthcare Service 

11.1. Medical Tourism Market, by Healthcare Service, 2023-2032

11.1.1. Medical Treatment

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Wellness

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Alternative Treatment

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Medical Tourism Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.1.3. Market Revenue and Forecast, by Type (2020-2032)

12.1.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.2.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.3.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.4.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.5.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Treatment Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Service Providers (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Healthcare Service (2020-2032)

Chapter 13. Company Profiles

13.1. Aditya Birla Memorial Hospital

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Apollo Hospitals Enterprise

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Asian Heart Institute

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Barbados Fertility Center

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Fortis Healthcare Limited

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. KPJ Healthcare Berhad

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. NTT Medical Center Tokyo

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Prince Court Medical Centre

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Samitivej PCL

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Seoul National University Hospital

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample